What is SamaCare?
SamaCare operates a sophisticated cloud-based workflow automation platform designed to optimize the specialty drug ecosystem. By facilitating seamless prior authorization, enrollment, and benefit verification, the company effectively reduces the administrative burden on medical practices specializing in high-acuity fields such as oncology, neurology, and rheumatology. Beyond its core automation tools, SamaCare provides pharmaceutical brands with actionable data analytics, enabling them to improve therapy access and patient outcomes. Its market position is defined by its ability to integrate disparate stakeholders—including payors, providers, and manufacturers—into a unified, efficient digital environment that prioritizes patient care over bureaucratic friction.
How much funding has SamaCare raised?
SamaCare has raised a total of $31.1M across 3 funding rounds:
Unspecified
$2.1M
Series A
$12M
Series B
$17M
Unspecified (2019): $2.1M, investors not publicly disclosed
Series A (2022): $12M led by NextView Ventures, Vive Collective, and South Park Commons
Series B (2024): $17M supported by South Park Commons, Vive Collective, and Questa Capital
Key Investors in SamaCare
South Park Commons
South Park Commons is a community designed for talented technologists, builders, and domain experts who are navigating the transition from prior projects to new ventures, fostering collaboration and providing mentorship to select entrepreneurs.
Vive Collective
Vive Collective is a platform designed to build, fund, and scale digital health companies by providing continuous funding and resources, with a specific focus on addressing the unique challenges faced by healthcare startups.
Questa Capital
Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health through strategic partnerships and operational support.
What's next for SamaCare?
With the successful closure of its latest funding round, SamaCare is poised to scale its operations significantly. The strategic focus will likely shift toward expanding its footprint within the specialty pharmacy landscape and deepening its data analytics capabilities to provide even greater value to pharmaceutical partners. As the healthcare industry continues to prioritize digital transformation and cost-effective therapy delivery, SamaCare's platform is uniquely positioned to capture additional market share. Future initiatives will likely involve enhancing interoperability with electronic health record systems and broadening the scope of its therapeutic coverage, ensuring that life-changing treatments reach patients with minimal delay. The company remains a key entity to watch as it navigates the complexities of the modern healthcare regulatory and operational landscape.
See full SamaCare company page
